# DLBS1033 for the Treatment of Acute Ischemic Stroke

> **NCT02362984** · PHASE3 · TERMINATED · sponsor: **Dexa Medica Group** · enrollment: 9 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Placebo
- **DRUG:** DLBS1033

## Key facts

- **NCT ID:** NCT02362984
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2017-02
- **Final completion:** 2017-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Major technical hindrance in recruitment.
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02362984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02362984, "DLBS1033 for the Treatment of Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02362984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*